Tag: StockMarket

Be in the know. 17 key reads for Friday…

  1. Tech Companies Just Reported Earnings. What to Know. (Barron’s)
  2. Facebook Stock Slips After Earnings. They Were Good but the Outlook Isn’t Rosy. (Barron’s)
  3. Alphabet Sales Growth Returns to Pre-Pandemic Level. The Stock Is Soaring. (Barron’s)
  4. Stocks Fell on Covid Fears. Treasury Yields Didn’t Follow Along. (Barron’s)
  5. How to Use the Election to Buy Stocks at a Bargain Price (Barron’s)
  6. After the Election, Managed-Care Stocks Tend to Rise. Anthem Is a Good Candidate for a Run. (Barron’s)
  7. U.S., China Friction Will Persist After the Election. Here’s What Investors Should Expect. (Barron’s)
  8. Here are 5 quality ‘election-proof’ stocks with upside potential, analyst says (MarketWatch)
  9. GDP Growth Was Massive. (Barron’s)
  10. Exxon to Slash U.S. Workforce (Barron’s)
  11. Apple iPhone Delay Hurt China Sales, Leaving a Lot Riding on 5G (Bloomberg)
  12. Megacap Tech Disappoints Market Where Nothing’s Good Enough (Bloomberg)
  13. At least until the pandemic, the president’s unconventional policy got unprecedented results. (Bloomberg)
  14. Dr. Paul Marik: Ivermectin Works and Should be Accepted for Large Observational Studies (TrialSiteNews)
  15. Gilead’s Covid-19 Drug Is Mediocre. It Will Be a Blockbuster Anyway. (New York Times)
  16. In Battleground Pennsylvania, Fracking and Renewables Compete to Be the Future of Energy (Wall Street Journal)
  17. Shell Tries to Woo Investors With Dividend Raise, Promise of Future Payouts (Wall Street Journal)

Be in the know. 20 key reads for Thursday…

  1. Regeneron: Trial COVID-19 drug cocktail cut virus load in more people (MarketWatch)
  2. In Leaked Remarks Among Hedge Fund Managers, Citadel’s Ken Griffin Open Up on Taxes (Institutional Investor)
  3. US Q3 GDP rose 33.1%, beating estimates of 32% (Yahoo! Finance)
  4. Riding The Waves. The Energy Report 10/29/2020 (Phil Flynn)
  5. Marvell Agrees to Buy Data Center Chip Maker Inphi for $10 Billion (Barron’s)
  6. Gilead Sciences raked in nearly $900M from COVID-19 drug remdesivir (New York Post)
  7. Forget the Polls: This Chinese Indicator Is Flashing ‘Trump’ (New York Times)
  8. RPT-UPDATE 3-Exxon Mobil to keep dividend flat for first time since 1982 (Reuters)
  9. UPDATE 2-Rise in at-home cooking helps Kraft Heinz beat sales expectations (Reuters)
  10. Molson Coors stock shoots up after big profit beat (MarketWatch)
  11. General Electric price target raised to $11 from $10 at Goldman Sachs (TheFly)
  12. Shell raises dividend as it seeks to woo shareholders (Financial Times)
  13. ‘Valuation leaves little room for error’: Here’s what 4 Wall Street banks expect from Apple’s fiscal 4th-quarter earnings report (Business Insider)
  14. ‘Anticipate upside to Q3 results’: Here’s what 6 Wall Street analysts are saying about Facebook before its 3rd quarter earnings report (Business Insider)
  15. U.S. Jobless Claims Declined More Than Forecast Last Week (Bloomberg)
  16. Pelosi Hopes Market Rout Pushes Trump Into a Stimulus Deal (Bloomberg)
  17. ECB Signals December Stimulus Likely Amid European Lockdowns (Bloomberg)
  18. Apple Faces Antitrust Complaint in France Over Privacy Changes in iPhones (Wall Street Journal)
  19. Trump Administration Releases Plan to Ensure Coronavirus Vaccines Are Free (Wall Street Journal)
  20. U.S. Car Business Vrooms Back From Pandemic Nadir (Wall Street Journal)